Wednesday, November 18, 2026 Daily Briefing News Quiz
Just in

Topics

Novo Nordisk

Every story about Novo Nordisk, updated as news breaks.

4 stories·Updated

What to know

  • FDA added new warnings to Ozempic, Zepbound, Wegovy and Mounjaro for NAION risk. Nov 9
  • Patients should watch for sudden vision loss or blurred vision and report changes immediately. Nov 9
  • Retatrutide reduced A1C 2.2% after 80 weeks, higher than Ozempic’s 1.8%. Oct 28
  • Highest dose of retatrutide led to 44‑47 lb weight loss, about double Ozempic’s effect. Oct 28
  • Amazon’s program bundles primary care, pharmacy and virtual care to simplify obesity treatment. Apr 21

Timeline

  1. Nov 9, 2026
  2. Oct 28, 2026
  3. Apr 21, 2026
  4. Dec 22, 2025